Emtricitabin/Tenofovirdisoproxil Hormosan

Emtricitabine/Tenofovir Disoproxil Hormosan is an oral medication used for HIV treatment and prevention. This combination therapy helps manage HIV infection and reduce viral load.

Emtricitabine/Tenofovir Disoproxil Hormosan is primarily used in the treatment of HIV-1 infection in adults and adolescents. It is also used for pre-exposure prophylaxis (PrEP) to prevent HIV infection in high-risk individuals. This medication works by reducing the amount of HIV in the body, helping to control the infection and improve the immune system.

Common effects of Emtricitabine/Tenofovir Disoproxil Hormosan may include headache, nausea, diarrhea, and dizziness. Some individuals may experience changes in mood or sleep patterns. These effects vary and are not experienced by everyone.

Emtricitabine/Tenofovir Disoproxil Hormosan should be used with caution in individuals with kidney problems. Regular monitoring of kidney function is recommended. It is important to follow the advice of a healthcare provider regarding the use of this medication.

Emtricitabine/Tenofovir Disoproxil Hormosan may interact with other medications, including those used to treat HIV, hepatitis B, and certain antibiotics. It is important to inform a healthcare provider about all medications being taken to avoid potential interactions.